What is Global Fast-disintegrating Tablets Market?
The Global Fast-disintegrating Tablets Market is a rapidly growing sector in the pharmaceutical industry. These tablets are a unique form of medication that disintegrates and dissolves rapidly in the mouth, without the need for water. This makes them an ideal choice for patients who have difficulty swallowing traditional tablets or capsules, such as the elderly or children. The market for these tablets is expanding globally due to their convenience and ease of use. They are also beneficial for patients who are on the go or have limited access to water. The fast-disintegrating tablets are designed to dissolve quickly in the patient's mouth, allowing for the rapid absorption of the medication into the bloodstream. This leads to a faster onset of action compared to traditional tablets, which must first be broken down in the digestive system.
Anti-Psychotics Drug, Anti-Epileptics Drug, Other in the Global Fast-disintegrating Tablets Market:
The Global Fast-disintegrating Tablets Market is segmented based on the type of drug they contain. This includes Anti-Psychotics Drugs, Anti-Epileptics Drugs, and others. Anti-psychotics drugs are used to treat mental health conditions such as schizophrenia and bipolar disorder. They work by altering the effects of chemicals in the brain. Fast-disintegrating anti-psychotic tablets can provide rapid relief from symptoms, making them a valuable tool in the management of these conditions. Anti-epileptic drugs are used to control seizures in conditions like epilepsy. Fast-disintegrating forms of these drugs can provide quick control of seizures, which can be life-saving in some cases. Other drugs that can be found in fast-disintegrating tablets include pain relievers, antihistamines, and more. Each of these drugs has its own benefits and uses, and the fast-disintegrating form can enhance their effectiveness.
CNS Diseases, Gastrointestinal Diseases, CVS Diseases, Other in the Global Fast-disintegrating Tablets Market:
Fast-disintegrating tablets are used in a variety of medical fields, including the treatment of CNS Diseases, Gastrointestinal Diseases, CVS Diseases, and others. In CNS diseases like Parkinson's and Alzheimer's, these tablets can provide rapid symptom relief. For gastrointestinal diseases like GERD and IBS, fast-disintegrating tablets can provide quick relief from symptoms like heartburn and abdominal pain. In CVS diseases like hypertension and heart failure, these tablets can help to quickly control symptoms and prevent complications. Other uses for fast-disintegrating tablets include the treatment of allergies, pain management, and more. The wide range of uses for these tablets is a major factor driving their increasing popularity in the global market.
Global Fast-disintegrating Tablets Market Outlook:
Looking at the market outlook, the Global Fast-disintegrating Tablets Market was valued at a significant US$ 15320 million in 2023. The market is expected to witness a substantial growth, reaching an estimated value of US$ 33020 million by 2030. This represents a compound annual growth rate (CAGR) of 11.7% during the forecast period from 2024 to 2030. This growth can be attributed to the increasing demand for convenient and easy-to-use medication forms, especially among the elderly and pediatric population. The market growth is also driven by the wide range of applications of fast-disintegrating tablets in various medical fields.
| Report Metric | Details |
| Report Name | Fast-disintegrating Tablets Market |
| Accounted market size in 2023 | US$ 15320 million |
| Forecasted market size in 2030 | US$ 33020 million |
| CAGR | 11.7% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb, Conquer |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
